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Abstract
Background: Upon return from space many astronauts experience symptoms of orthostatic
intolerance. Research has implicated altered autonomic cardiovascular regulation due to spaceflight
with further evidence to suggest that there might be pre-flight autonomic indicators of post-flight
orthostatic intolerance. We used heart rate variability (HRV) to determine whether autonomic
regulation of the heart in astronauts who did or did not experience post-flight orthostatic
intolerance was different pre-flight and/or was differentially affected by short duration (8 – 16 days)
spaceflight. HRV data from ten-minute stand tests collected from the 29 astronauts 10 days pre-
flight, on landing day and three days post-flight were analysed using coarse graining spectral analysis.
From the total power (PTOT), the harmonic component was extracted and divided into high (PHI:
>0.15 Hz) and low (PLO: = 0.15 Hz) frequency power regions. Given the distribution of autonomic
nervous system activity with frequency at the sinus node, PHI/PTOT was used as an indicator of
parasympathetic activity; PLO/PTOT as an indicator of sympathetic activity; and, PLO/PHI as an
estimate of sympathovagal balance.
Results: Twenty-one astronauts were classified as finishers, and eight as non-finishers, based on
their ability to remain standing for 10 minutes on landing day. Pre-flight, non-finishers had a higher
supine PHI/PTOT than finishers. Supine PHI/PTOT was the same pre-flight and on landing day in the
finishers; whereas, in the non-finishers it was reduced. The ratio PLO/PHI was lower in non-finishers
compared to finishers and was unaffected by spaceflight. Pre-flight, both finishers and non-finishers
had similar supine values of PLO/PTOT, which increased from supine to stand. Following spaceflight,
only the finishers had an increase in PLO/PTOT from supine to stand.
Conclusions: Both finishers and non-finishers had an increase in sympathetic activity with stand
on pre-flight, yet only finishers retained this response on landing day. Non-finishers also had lower
sympathovagal balance and higher pre-flight supine parasympathetic activity than finishers. These
results suggest pre-flight autonomic status and post-flight impairment in autonomic control of the
heart may contribute to orthostatic intolerance. The mechanism by which higher pre-flight
parasympathetic activity might contribute to post-flight orthostatic intolerance is not understood
and requires further investigation.
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Upon return from spaceflight many astronauts are unable
to tolerate upright posture without experiencing symp-
toms related to fainting. This high degree of orthostatic
intolerance (OI) observed in astronauts after spaceflight
indicates probable altered cardiovascular regulation upon
return. Early spaceflight data, as well as studies utilizing
6° head-down tilt bed rest (HDBR) to simulate weight-
lessness, have shown reduced plasma volume and
decreased baroreflex response, post-exposure [1-9]. There
is evidence of altered autonomic cardiovascular control
with a reduction in parasympathetic regulation as well as
possible changes in sympathetic cardiovascular regulation
following real or simulated spaceflight. However, new evi-
dence indicates that pre-flight physiology may also play
an important role [10-12].
Investigations of the cardiovascular differences between
astronauts who did, or did not, finish a post-flight stand
test have revealed pre-flight differences. Compared to fin-
ishers, non-finishers had higher parasympathetic tone
[12], lower supine and standing peripheral vascular resist-
ance [11] and systolic blood pressure [10,11] as well as
lower standing diastolic blood pressure [11]. Post-flight,
finishers had higher catecholamine levels and vasocon-
strictor response to standing compared to non-finishers
[10,11].
Although Fritch-Yelle et al. [11] concluded that post-flight
presyncope might be due to centrally mediated hypoad-
renergic responsiveness, this has recently been challenged
[13]. Based on an investigation into the mechanisms lead-
ing to syncope in healthy individuals, Evans et al. [13] sug-
gested that presyncopal astronauts may have had similar
or higher rates of norepinephrine release since the accu-
mulation time for norepinephrine was shorter due to ter-
mination of the stand test.
It is evidence that the importance of the effect of space-
flight on autonomic responses to post-flight orthostatic
stress and the effect pre-flight autonomic status on post-
flight OI is not well understood. In the present study, we
used HRV analysis to further investigate the relationship
between spaceflight and autonomic regulation of the
heart on orthostatic intolerance in a group of astronauts
for whom measures of catecholamines and total periph-
eral resistance indicated that post-flight OI was associated
with low sympathetic response to standing pre- and post-
short duration spaceflights [11].
Due to the nature of the interaction of the parasympa-
thetic and sympathetic nervous systems on the heart, with
the parasympathetic decreasing and the sympathetic
increasing heart rate, a single measurement of heart rate
may be the result of a variety of combinations of parasym-
pathetic and sympathetic activity. On the other hand,
heart rate variability (HRV) analyses, in the frequency
domain, the dynamic response of the heart rate to these
inputs [14]. Two major spectral components have been
identified: a low frequency (LF) and a high frequency
(HF) component that can be used to provide indicators of
sympathetic and parasympathetic modulation of heart
rate [14,15]. Because of this, the use of HRV has proven to
be a more powerful tool, than the recording of average
heart rate, in the investigation of autonomic control of the
heart and is now the most common method used to pro-
vide non-invasive indicators of the autonomic nervous
system [14]. A number of studies have used spectral anal-
ysis of HRV during simulated weightlessness to investigate
the effects of spaceflight on autonomic cardiovascular
control. A consistent decrease in the parasympathetic
nervous system indicator has been observed [16-18],
whereas both an increase [17] and no change [16,18] in
the sympathetic nervous system indicator has been
reported after head down tilt bed-rest.
The aims of this study were: 1) to assess HRV as an appro-
priate tool to measure autonomic function pre- and post-
spaceflight; 2) to determine whether the effects of space-
flight on the autonomic regulation of the heart were dif-
ferent between astronauts who did or did not experience
post-flight OI; and, 3) whether pre-flight HRV was differ-
ent between astronauts who did or did not experience
post-flight OI.
Results
Two of the eight subjects who were unable to complete
the 10 minute landing day stand test [11] had insufficient
data lengths during the standing portion of the test to per-
form spectral analysis. Analysis of HRV was therefore lim-
ited to six subjects in the stand portion of landing day in
the non-finisher group. The RR-interval time series and
the corresponding harmonic power spectra for a non-fin-
isher, during the three stand tests, is shown in Figure 1 and
that of a finisher in Figure 2. For comparative purposes
each of the power spectra were normalized to the total
spectral power during the respective pre-flight supine
condition.
Non-finishers versus finishers
On all test days the ratio PLO/PHI was lower in non-finish-
ers compared to finishers (p = 0.016) and was unaffected
by spaceflight (Table 1).
Pre-flight, non-finishers had a higher PHI/PTOT (parasym-
pathetic indicator) than finishers (Figure 4, p < 0.001) and
both finishers and non-finishers had similar supine values
of PLO/PTOT, which increased from supine to stand (finish-
ers: p < 0.001; non-finishers: p = 0.016, Table 1).Page 2 of 11
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BMC Physiology 2004, 4 http://www.biomedcentral.com/1472-6793/4/6Data from an astronaut who could not complete the landing day ten-minute stand test (non-finisher)Figure 1
Data from an astronaut who could not complete the landing day ten-minute stand test (non-finisher). Pre-flight (top figure), 
landing day (middle figure) and post-flight (bottom figure) RR-interval time series are presented with the onset of standing 
marked as time 0-minutes. Supine data are on the left (negative times) and stand data on the right (positive times). The gap 
between -9 and -2 minutes represents the 7-minute carbon-monoxide test for blood volume measurements [11]. Subjects 
maintained a fixed breathing rate of 15 breaths per minute (0.25 Hz) during the five minutes prior to the carbon monoxide test 
and during the first five minutes of the stand test. The harmonic spectral power (PHARM) generated from coarse graining spec-
tral analysis of RR-interval in each of the data segments are presented below the supine and above the stand RR-interval data. 
For comparison over test conditions and with the example finisher astronaut (Figure 2), at each frequency harmonic spectral 
power was normalized with the pre-flight supine total power (PTOT) and are presented in normalized units (n.u.: PHARM / PTOT).
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BMC Physiology 2004, 4 http://www.biomedcentral.com/1472-6793/4/6Data from an astronaut who could complete the landing day ten-minute stand test (finisher)Figure 2
Data from an astronaut who could complete the landing day ten-minute stand test (finisher). Pre-flight (top figure), landing day 
(middle figure) and post-flight (bottom figure) RR-interval time series are presented with the onset of standing marked as time 
0-minutes. Supine data are on the left (negative times) and stand data on the right (positive times). The gap between -9 and -2 
minutes represents the 7-minute carbon-monoxide test for blood volume measurements [11]. Subjects maintained a fixed 
breathing rate of 15 breaths per minute (0.25 Hz) during the five minutes prior to the carbon monoxide test and during the 
first five minutes of the stand test. The harmonic spectral power (PHARM) generated from coarse graining spectral analysis of 
RR-interval in each of the data segments are presented below the supine and above the stand RR-interval data. For comparison 
over test conditions and with the example non-finisher astronaut (Figure 1), at each frequency harmonic spectral power was 
normalized with the pre-flight supine total power (PTOT) and are presented in normalized units (n.u.: PHARM / PTOT).
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BMC Physiology 2004, 4 http://www.biomedcentral.com/1472-6793/4/6On landing day, compared to pre-flight, only the non-fin-
ishers had an overall decrease in PHI/PTOT (Figure 3, p <
0.0001). PHI/PTOT was not different between finishers and
non-finishers on landing day (Figure 3, p < 0.0001).
Although finishers and non-finishers had similar supine
values for PLO/PTOT, only the finishers had an increase in
PLO/PTOT from supine to stand on landing day (p < 0.001,
Table 1).
Three days after landing, overall PHI/PTOT, was again
higher (p = 0.025) in the non-finisher compared to the
finisher group (Table 1, Figure 3). Similar to landing day,
three days post-flight, only the finishers had an increase in
PLO/PTOT from supine to stand (Table 1, p < 0.001).
General effects of spaceflight
When going from supine to standing, RR-interval, PHI,
PTOT, and PHI/PTOT decreased and PLO/PHI increased, on all
test days (Table 1, all p < 0.015).
Low frequency power, PLO, increased with stand pre-flight
but not on landing day or three days post-flight (Table 1).
Spaceflight had the effect of reducing mean RR-interval (p
< 0.001) on landing day but had recovered to pre-flight
values three days after landing (Table 1). Overall, the
standing parasympathetic indicator, PHI/PTOT, was also
reduced on landing day (p < 0.0001) and three days post-
flight (p < 0.01) (Figure 3).
Discussion
We have analysed the data from a group of 29 astronauts
who were able to complete a ten minute pre-flight stand
tests, eight of which could not complete the same test on
landing day [11]. The coarse graining spectral analysis of
HRV showed similar differences in sympathetic responses
to standing between finishers and non-finishers pre- and
post-flight, as was seen with the more elaborate and inva-
sive catecholamine measurements in these same astro-
nauts [11]: PLO/PHI was lower in non-finishers compared
to finishers, and, in the non-finishers, PLO/PTOT did not
increase with stand post-flight.
We present further evidence that there are specific pre-
flight characteristics in autonomic function that distin-
guish non-finishers from finishers. Both groups had simi-
lar reductions in RRI on landing day and due to standing
(Table 1), but power spectral analysis of RR-interval dur-
ing the stand test revealed differences in autonomic func-
tion before and after short duration spaceflight,
characteristics that may be associated with increased sus-
ceptibility to OI following up to 16 days of
weightlessness.
There was significantly higher supine parasympathetic
activity (PHI/PTOT) in the non-finishers compared to fin-
ishers pre-flight; however, this difference disappeared
upon standing. Furthermore, the non-finishers also had a
decrease in supine PHI/PTOT from pre-flight to landing day
Table 1: Coarse graining spectral analysis (CGSA) of heart rate variability in finisher and non-finisher astronauts.
Main effects Group Pre-flight Landing day 3 days post-flight Inter-actions
Supine Stand Supine Stand Supine Stand
subjects F 21 21 21 21 21 21
NF 8 8 8 6 8 8
RRI (ms) * † F 1146(34) 846(22) 1020(27) 692(21) 1085(36) 806(23)
NF 1140(80) 807(38) 1040(81) 705(84) 1104(96) 768(36)
PTOT (ms2) * F 2299(486) 1292(271) 2672(276) 687(129) 2816(587) 877(105)
NF 1564(320) 953(266) 2632(453) 3326(293) 3433(1195) 853(182)
PHI (ms2) * F 417(25) 9(2) 151(51) 4(1) 212(46) 19(55)
NF 349(87) 32(18) 316(194) 49(48) 440(123) 45(94)
PHI/PTOT * # † F 0.14(0.02) 0.01(0.01) 0.09(0.02) 0.01(0.01) 0.08(0.02) 0.01(0.01) a, b
NF 0.25(0.06) 0.05(0.03) 0.10(0.03) 0.01(0.01) 0.15(0.05) 0.05(0.03)
PLO (ms2) F 134(37) 321(74) 222(74) 194(44) 220(63) 199(45) a
NF 92(51) 171(55) 201(101) 60(11) 334(124) 100(21)
(PLO/PHI)1/2 * # F 0.80(0.15) 7.20(0.90) 2.30(0.62) 8.05(1.06) 4.8(1.22) 8.07(0.96)
NF 0.51(0.32) 3.98(1.18) 0.94(0.28) 4.75(1.89) 0.07(0.33) 3.45(1.00)
PLO/PTOT * F 0.08(0.02) 0.23(0.03) 0.10(0.03) 0.26(0.03) 0.09(0.04) 0.19(0.03) b, d
NF 0.04(0.01) 0.17(0.05) 0.10(0.03) 0.11(0.03) 0.10(0.05) 0.13(0.03)
Values are presented as mean (standard error). Finishers (F); non-finishers (NF); PTOT: total power; PHI: high frequency power; PHI/PTOT: 
parasympathetic indicator; PLO: low frequency power; (PLO/PHI)1/2: normalized sympathovagal balance; PLO/PTOT: sympathetic nervous system 
indicator. Main effects symbols denote values different (p < 0.05) from: *, supine to stand; #, finishers and non-finishers; and †, over test days. 
Interaction symbols represent effects (p < 0.05) between: a, stand test and test day; b, stand test and group; c, test day and group; d, test day, 
group and stand test. The two-way interactions for PHI/PTOT are presented in Figure 3. The three-way interaction for PLO/PTOT is presented in the 
table with bold type to represent the regions where non-finishers responded differently to the stand test compared to the finishers.Page 5 of 11
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BMC Physiology 2004, 4 http://www.biomedcentral.com/1472-6793/4/6three times that of the finishers. Similar results were found
between cosmonauts who could or could not finish a 5-
minute post-flight stand test following long duration
spaceflight (90–198 days) [12]. The mechanism by which
higher pre-flight parasympathetic tone might contribute
to post-flight OI is not understood [12]. Higher resting
parasympathetic control of heart rate is usually associated
with reduced sympathetic control. It is possible that para-
sympathetic activity and its changes to stand and space-
flight is an indicator of a broader difference in autonomic
status, both parasympathetic and sympathetic, between
non-finishers and finishers.
The indicator associated with the sympathetic nervous
system, PLO/PTOT also showed fundamental differences
between finishers and non-finishers. However, unlike the
parasympathetic indicator these differences were only
observed post-flight. Pre-flight, both finishers and non-
finishers had similar supine PLO/PTOT, with similar
increases in PLO/PTOT from supine to stand (Table 1). With
the finishers, the supine and stand values for PLO/PTOT
were unchanged from pre-flight to landing day and three
days post-flight; however, with the non-finishers, PLO/
PTOT did not increase with stand on either landing day or
three days post-flight. These data would suggest that car-
diac sympathetic activation from supine to stand was
impaired post-flight in the non-finishers compared to the
finishers and are consistent with a reduced rate of sympa-
thetic response to stand post-flight. This may have con-
tributed to decreased cardiac filling and inadequate stroke
volume which ultimately resulted in postural
hypotension.
These data support previous reports of landing day
hypoadrenergic responsiveness in the non-finishers [11].
However, unlike the previous investigation of this group
of astronauts [11] these estimates of autonomic function
were performed over the same time period in both finish-
ers and non-finishers and after the first minute of the
stand test, not at the end.
Direct measurements of peripheral sympathetic activity
during simulated weightlessness through muscle sympa-
thetic nerve activity (MSNA) have produced differing
results. In one study with 14 days of HDBR lower MSNA
was observed during head-up tilt compared to pre-HDBR
[19], while in two others an overall increase in MSNA
(supine and orthostatic stress) was observed after three
days of dry immersion [20] and after 60 and 120 days of
HDBR [21]. Results from MSNA measurements made
before and after spaceflight showed an increase in MSNA
activation during head-up tilt post-flight compared to pre-
flight [22]. Total peripheral resistance and cardiac stroke
volume were decreased post-flight whereas heart rate was
increased with no change in arterial blood pressure.
Unfortunately even though quality signals were collected,
none of the six male astronauts tested orthostatically
intolerant upon return to Earth and the effects of space-
flight on OI could not be investigated. Our data and those
from studies of MSNA show, that in subjects that do not
suffer OI, peripheral and cardiac sympathetic activity are
sufficient to maintain blood pressure.
In normal subjects, a change from supine to stand causes
a shift to greater sympathetic over parasympathetic regu-
lation of cardiac function with a corresponding increase in
sypathovagal balance, PLO/PHI. Our data show this change
in both groups of astronauts pre-flight, but the non-fin-
ishers had lower values than finishers. These were unaf-
fected by spaceflight and suggests that the relationship
between sympathetic and parasympathetic modulation of
The parasympathetic nervous system indicatorFigure 3
The parasympathetic nervous system indicator. The para-
sympathetic nervous system (PNS) indicator pre-flight, land-
ing day and post-flight with respect to the stand test (3A) and 
susceptibility to landing day orthostatic intolerance (3B). 
Symbols denote values different (p < 0.05) from: *, supine or 
finisher, and #, pre-flight.
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BMC Physiology 2004, 4 http://www.biomedcentral.com/1472-6793/4/6heart rate is preserved in the non-finishers following short
duration spaceflight despite the changes observed in par-
asympathetic and sympathetic activity. In an investigation
of HRV in cosmonauts after long duration spaceflight
[12], PLO/PHI was found to increase only in the non-finish-
ers both pre-flight and post-flight, however, a low number
of finishers during stand in both the pre-flight (n = 5) and
post-flight tests (n = 5) may have contributed to the lack
of an observed increase in PLO/PHI [12].
Exercise is a physiological perturbation that significantly
affects autonomic nervous activity. Research has indicated
that long-term endurance training increases heart rate var-
iability, increases parasympathetic activity, and decreases
sympathetic activity to the human heart at rest [23-27].
Orthostatic tolerance also appears to be decreased by the
improved cardiovascular function associated with
physical conditioning [28-31]. As part of the test protocol
we did not evaluate individual fitness levels. All astro-
nauts undergo rigorous physical training, including
endurance exercise, prior to flight, and variation in pre-
flight fitness may have been a contributing factor.
In addition to fitness level, astronaut gender may also play
a role in susceptibility to post-flight OI. In this data set,
five of eight non-finishers were female, while 19 of 21 fin-
ishers were male [11]. A compilation of statistics (25
female, 140 male) on incidence of presyncope after short
duration spaceflight (5–16 days) showed a similar effect,
with presyncope occurring in 28% of the females and 7%
in the males [32] and is associated with low vascular
resistance [33] There is growing body of evidence to sug-
gest that autonomic cardiovascular control is different
between males and females both at rest [34] and when
exposed to orthostatic stress [35-37]. At rest the parasym-
pathetic nervous system is a more dominant influence of
heat rate variability in women than in men [34]. Women
also respond to cardiovascular stress with greater heart
rate increases through parasympathetic withdrawal,
whereas men respond primarily with greater increases in
vascular resistance through sympathetic control of periph-
eral vasoconstriction [35-38].
Our data clearly show that the non-finishers have higher
parasympathetic activity pre-flight than the finishers and
have lower pre-flight PLO/PHI. As well this group also had
smaller increases in total peripheral resistance during the
pre-flight stand test [11]. It could be argued that these data
are representative of female subjects since the majority of
the non-finishers were female, yet, others [12] have
shown a similar pre-flight relationship between non-fin-
ishers and PLO/PHI. Given the distribution of sympathetic
versus parasympathetic cardiovascular control between
genders we could expect there to be representation of both
males and females at either end of the PLO/PHI range.
However, as one moves to the extremes at either ends of
the range (high sympathetic to parasympathetic or low
sympathetic to parasympathetic ratio) a specific gender
will dominate. It should not be surprising to find male
subjects in the region containing mainly female subjects.
As a group, the non-finishers also had a significant reduc-
tion in supine parasympathetic and standing sympathetic
activity on landing day such that sympathovagal balance
was preserved. This suggests an interaction between
sympathetic and parasympathetic control of heart rate
during spaceflight to maintain PLO/PHI. Given these
changes in autonomic function from pre-flight to landing
day the non-finishers, mostly women, who normally
respond to cardiovascular stress via greater parasympa-
thetic withdrawal than sympathetic activation, would be
compromised and more susceptible to OI.
Regardless of the underlying factors that contribute to the
autonomic relationship to post-flight OI, high parasym-
pathetic and low sympathetic activity pre-flight was asso-
ciated with reduced orthostatic tolerance post-flight. A
possible effect of reduced parasympathetic control at rest
would be the lack of buffering of blood pressure at the
beginning of orthostatic stress, thereby leading to reduced
orthostatic tolerance. Fadel et al. [39], further indicate that
vagal baroreflex control is pivotal to the reflex regulation
of heart rate and maintenance of arterial blood pressure
during dynamic and transient decreases in systemic blood
pressure. The strength of this relationship is most likely
related to the relative strength of the parasympathetic and
sympathetic control systems during day-to-day activities.
In those subjects with higher parasympathetic compared
to sympathetic tone, parasympathetic activity would be
expected to play a greater role. The reverse would also be
true. During weightlessness the arterial baroreceptor sys-
tem is rarely challenged due to the lack of postural fluctu-
ations in blood pressure. Upon return to Earth, this results
in reduced vagal tone. Unless a significant regulatory
mechanism remains to compensate for the sudden drop
in blood pressure on standing, the subject will be
orthostatically intolerant. Those subjects, in whom sym-
pathetic vascular resistance control was high before space-
flight, would not experience as great an effect during
orthostatic stress.
When interpreting HRV, care must be taken to ensure that
the data segment was obtained during steady state condi-
tions [14]. In this study, care was taken to ensure that data
used for HRV analysis was from segments that were closest
to being steady state. The subject was supine for at least
ten minutes before the baseline HRV analysis. Baseline
analysis was also performed prior to the carbon monoxide
(CO) rebreathe test for blood volume. During the stand
portion of the test, HRV analysis was not performed untilPage 7 of 11
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BMC Physiology 2004, 4 http://www.biomedcentral.com/1472-6793/4/6at least one minute had passed, allowing for heart rate and
blood pressure to stabilize (Figures 1 &2). This was at
three minutes after the CO-rebreathe protocol and at least
eight minutes after the inhalation of CO for the blood vol-
ume test. Analysis of the RR-interval in the two minutes
prior to and immediately following the CO test segment
indicated that there was no difference in mean RR-interval
or the standard deviation of RR-interval (see sample data,
Figures 1 &2) which would suggest that the CO-rebreathe
test did not affect the heart rate data.
We chose to use CGSA to investigate HRV due to its
unique ability to allow for investigation of fractal variabil-
ity. However, results from the harmonic component of
CGSA are compatible with those from a general spectral
analysis fast Fourier transform (FFT) using the Task Force
[14] guidelines. A standard FFT algorithm with a suitable
windowing function (Hanning window) applied to the
stand data (Table 2) demonstrates the compatibility of
CGSA with HRV guidelines [14]. Although the absolute
values determined by each method were different, the sig-
nificant main effects and interactions for PTOT, PHI and PLO
were the same. Not surprisingly, the normalized sym-
pathovagal balance estimate (PLO / PHI ratio) was also sim-
ilar between the two methods. In the case of the standard
FFT analysis, significance main effects were observed for
all three conditions (test day, supine/stand, finisher/non-
finisher) (Table 2); whereas, CGSA only found signifi-
cance for test day and supine/stand (Table 1).
With general FFT analysis, there is not a comparable para-
sympathetic indicator to CGSA's PHI/PTOT, since the latter
estimate relies on the extraction of harmonic and fractal
components to determine PHI [24,25]. Similarly, the
suggested sympathetic indicator for FFT and autoregres-
sive analysis (PLO/PTOT, 0.04–0.0.40 Hz) [26] will not be
the same as CGSA's PLO/PTOT. In fact, we see that due the
nature of the calculation of the FFT sympathetic indicator,
the results are identical to that found for sympathovagal
balance (Table 2). We suggest that our sympathetic indi-
cator (PLO/PTOT) provides important new information on
the relationship between low frequency HRV, orthostatic
intolerance and spaceflight.
Conclusion
In summary, we investigated heart rate variability at rest in
the supine position and in response to upright posture in
29 astronauts before and after spaceflights lasting up to 16
days. We separated individuals according to their ability
to remain standing without assistance for 10 min on land-
ing day. Although both finishers and non-finishers had an
increase in sympathetic activity with stand pre-flight, only
finishers retained this response post-flight. We also iden-
tified pre-flight autonomic responses that might separate
finishers and non-finishers. Both groups of astronauts had
the expected shift to greater sympathetic over parasympa-
thetic regulation (increased sympathovagal balance, PLO/
PHI) of cardiac function from supine to stand on all test
days. However, the non-finishers had lower values than
finishers did. That this was unaffected by spaceflight sug-
gests the relationship between sympathetic and parasym-
pathetic modulation of heart rate was preserved in both
groups following short duration spaceflight. Compared to
finishers, non-finishers had higher parasympathetic activ-
Table 2: Fast Fourier transform (FFT) analysis of heart rate variability [14] in finisher and non-finisher astronauts.
Main effects Group Pre-flight Landing day 3 days post-flight Inter-actions
Supine Stand Supine Stand Supine Stand
subjects F 21 21 21 21 21 21
NF 8 8 8 6 8 8
PTOT (ms2) * F 1055(165) 802(169) 875(174) 479(165) 1110(169) 559(179)
NF 930(286) 515(286) 1018(286) 362(309) 2124(338) 455(286)
PHI (ms2) * F 664(90) 51(92) 311(95) 35(90) 465(92) 78(97)
NF 542(155) 106(155) 544(155) 80(168) 1111(184) 118(155)
PLO (ms2) F 391(109) 752(112) 564(115) 444(109) 644(112) 482(119) a
NF 389(189) 408(169) 474(190) 282(205) 1013(224) 337(189)
(PLO/PHI)1/2 * # † F 20.9(1.5) 7.0(1.6) 15.6(1.6) 5.2(1.5) 19.4(1.6) 7.0(1.7)
NF 22.2(2.7) 9.9(2.7) 20.8(2.7) 7.2(2.9) 30.7(3.2) 9.3(2.7)
PLO/PTOT * # † F 0.47(0.03) 0.89(0.03) 0.64(0.03) 0.90(0.03) 0.56(0.03) 0.88(0.03)
NF 0.43(0.05) 0.76(0.05) 0.52(0.05) 0.83(0.05) 0.46(0.06) 0.78(0.05)
Values are presented as mean (standard error). Finishers (F); non-finishers (NF); PTOT: total power (0.04–0.40 Hz); PHI: high frequency power (0.15 
– 0.40 Hz); PLO: low frequency power (0.04 – 0.15 Hz); (PLO/PHI)1/2: normalized sympathovagal balance; PLO/PTOT: sympathetic nervous system 
indicator. Main effects symbols denote values different (p < 0.05) from: *, supine to stand; #, finishers and non-finishers; and †, over test days. 
Interaction symbols represent effects (p < 0.05) between: a, stand test and test day; b, stand test and group; c, test day and group; d, test day, 
group and stand test.Page 8 of 11
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pathetic activity might contribute to post-flight
orthostatic intolerance is not understood and needs to be
investigated further.
Methods
This protocol was approved by the Johnson Space Center
Human Research Policy and Procedures Committee. Forty
astronauts were familiarized with the study protocol and
data collection procedures 30 days pre-flight. Data used
for the study was collected 10 days before launch (base-
line, pre-flight), on landing day (1–2 h after landing), and
3 days after landing (post-flight), on shuttle missions last-
ing 8–16 days. Of the 40 original astronaut subjects, 7
were excluded from analysis because they had taken pro-
methazine or dextroamphetamine within 12 h or caffeine
within 4 h preceding the test on landing day [11]. Four
more subjects were excluded from HRV analysis because
their landing day catecholamine values were not available
for analysis in our previous paper [11] due to ruined
blood samples. Therefore, only 29 astronauts, whose
mean age was 39.8 ± 5.2 yr, were used in our analysis.
The research protocol and cardiovascular data for these
astronauts have already been presented [11]. On each test
day the subject had abstained from caffeine, alcohol, and
any medications for the preceding 12 hours; was at least 2
hours postprandial; and had not exercised heavily in 24
hours. Over a 10-minute period the subject was instru-
mented for blood pressure (Finapres, Ohmeda,
Inglewood, CO), heart rate, and transcranial Doppler
(Medasonics, Fremont, CA) measurements [11]. After
instrumentation, five minutes of supine data were col-
lected. During this period subjects paced their breathing
with an auditory signal at 15 breaths per minute. This was
followed by a change to the left lateral position for 7-min
to perform echocardiography and carbon monoxide
rebreathing [11].
Following the carbon monoxide rebreathe procedure, the
subjects were returned to the supine position and after 2-
min they were assisted to the standing position by three
investigators [11]. To minimize blood pressure changes
due to the effort of standing, subjects were lifted from
behind both shoulders while their feet were swept off the
bed [11]. The subjects remained unassisted in the
standing position for up to 10 min and were returned to
the supine position. Due to limited space within the crew
transport vehicle on landing day the assisted stand test
was used to approach as closely as possible the conditions
of a tilt test. During the first five minutes of the stand test
each subject was again requested to follow an auditory sig-
nal to pace their breathing at 15 breaths per minute. If the
subjects became presyncopal during the stand they were
returned immediately to the supine position. Subjects
were deemed to be presyncopal if the subject indicated
symptoms such as dizziness or nausea, or if we observed
any of the following: i) a decrease in HR of more than 15
beats per minute; ii) a decrease in systolic blood pressure
of more than 25 mm Hg/min; iii) a decrease in diastolic
BP of more than 15 mm Hg/min; or, iv) a decrease in tran-
scranial Doppler middle cerebral artery mean flow veloc-
ity of more than 15 cms-1/min.
Data collection
A standard three lead electrocardiograph was used to col-
lect the ECG signal. The analog signal was recorded simul-
taneously at 12 kHz using an eight-channel digital tape
recorder (TEAC RD-111T, Montebello, CA). Beat-by-beat
analysis of these data was performed off-line. The peak of
the R wave of the ECG tracings were marked by an auto-
mated computer system and manually reviewed for
anomalies and electrode movement artefact (due to venti-
lation or to cable movement) that may have affected this
process. These data were then used to generate an RR-
interval (RRI) time series.
Heart Rate Variability (HRV) analysis
For all subjects, heart rate variability analysis was per-
formed on 256 beat RRI time series segments obtained
during the five minute supine data collection and follow-
ing one minute of stand.
The heart rate signal has been shown to be fractal [40-42].
That is, a broad-band, non-white signal underlies the
(harmonic) variations that are normally taken to indicate
parasympathetic and sympathetic regulatory control of
the heart. We therefore chose to evaluate the beat-by-beat
variability of RR-interval with by coarse graining spectral
analysis (CGSA) [43] as this method has the ability to
extract the harmonic components from the fractal compo-
nents [43,44]. The algorithm has been described in detail,
along with a demonstration of its efficiency in extracting
harmonic from the fractal component, particularly in the
very low frequency region, to achieve better spectral esti-
mates with short data sets [43]. From the total power
(PTOT), the fractal (PFRAC) and harmonic (PHARM) compo-
nents are extracted. Although the recommended standard
for the lower limit of the low frequency range of heart rate
variability is 0.04 Hz [14], this was based on methods that
did not isolate harmonic from fractal and was designed to
minimize the effect of the fractal component on low fre-
quency power. However, the CGSA algorithm has been
demonstrated to be able to efficiently the extract
harmonic from the fractal component over the total fre-
quency range (0.0 – 0.50 Hz) [43].
The harmonic component can then be further divided
into two frequency regions; high frequency (HI, >0.15
Hz) and low frequency (0.0 – 0.15 Hz) [43]. The high fre-Page 9 of 11
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parasympathetic nervous system, whereas the low fre-
quency region is a consequence of several factors and is a
combination of both parasympathetic and sympathetic
nervous system activity. From these the integrated low fre-
quency (0.0 – 0.15 Hz, PLO) and high frequency (0.15 –
0.50 Hz, PHI) power can be determined.
Given the distribution of sympathetic and parasympa-
thetic nervous system activity with frequency at the sinus
node, PHI/PTOT can be used as an indicator of parasympa-
thetic activity and PLO/PHI has been used as an indicator of
sympathetic activity in control of heart rate [45,46] or
sympathovagal balance [47]. Previously we found that
due to the large possible range of values generated by this
ratio, especially as PHI decreases with orthostatic stress,
this number should be normalized by taking its square
root [15]. In effect, this is then the ratio of the amplitudes
of the low and high frequency regions [15]. It has been
suggested that modulation of sympathetic activity on the
heart is best estimated when normalized to total power
(PLO/PTOT) rather than PHI [47]. Although the computa-
tion of the powers by CGSA is different from the autore-
gressive technique used in the above research, we have
also included PLO/PTOT, as determined by CGSA, in our
analyses.
This method relies on the respiratory frequency residing
above 0.15 Hz. Although we were not able to measure
ventilation in these subjects, an attempt was made to
achieve this important criterion [14] by requesting the
subjects breathe at 15 breaths per minute (0.25 Hz). Anal-
ysis of HRV revealed a frequency peak above 0.15 Hz in all
subjects.
Statistics
Subjects were grouped based on presence or absence of
presyncope on landing day. All individual data groups
(i.e. standing in non-finisher group on landing day) were
found to be normally distributed using the 'Kolmogorov-
Smirnov' test for normality. A repeated measures analysis
of variance of test day (pre-flight, landing day, 3 days post
flight), stand test (supine, stand) and group (finishers,
non-finishers) factors was used with group nested within
subjects. The JMP-IN statistical package (SAS Institute
Inc.) was used. Due to the missing data from two of the
non-finisher subjects during the stand test on landing day,
comparisons of finishers and non-finishers was per-
formed using an estimated mean square error. Post hoc
analyses using a Student-Newman-Keuls test were per-
formed on specific comparisons related to our hypothe-
ses. These were considered significant if the probability
was less than 0.05 (p < 0.05). All data are quoted as mean
± SEM (standard error of the mean).
List of abbreviations
OI orthostatic intolerance
HDBR 6° head-down tilt bed rest
MSNA muscle sympathetic nerve activity
F finishers of landing day 10 minute stand test
NF non- finishers of landing day 10 minute stand test
HRV heart rate variability
LF low frequency
HF high frequency
CGSA coarse graining spectral analysis
PTOT total power
PFRAC fractal power
PHARM harmonic power
PLO harmonic low frequency power (0.0 – 0.15 Hz)
PHI harmonic high frequency power (0.15 – 0.50 Hz)
PHI/PTOT indicator of parasympathetic activity
PLO/PHI sympathovagal balance
PLO/PTOT indicator of sympathetic activity
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